#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	686	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1160	31.7	0	.	p	.	0	K29T	NONSYN	85	87	AAG	365	367	ACG	29;28;27	A;C;G	29;28;27	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2484	Escherichia_coli_EF_Tu	1230	1208	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	83.7	1	SNP	p	R234F	1	.	.	700	702	TTC	956	958	TTC	119;117;117	T;T;C	118;115;114	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2484	Escherichia_coli_EF_Tu	1230	1208	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	83.7	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1256	1258	CGT	123;121;121	C;G;T	121;120;120	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2484	Escherichia_coli_EF_Tu	1230	1208	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	83.7	0	HET	.	.	.	T180C	.	180	180	T	436	436	T	72	T,C	49,20	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2484	Escherichia_coli_EF_Tu	1230	1208	99.67	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1464	83.7	0	HET	.	.	.	C255T	.	255	255	C	511	511	C	90	C,T	49,41	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	2484	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	250	14.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	1144	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	1838	33.4	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1558	1560	AAA	20;20;20	A;A;A	20;20;20	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	1376	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1865	39.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1372	1374	GAA	67;66;65	G;A;A	67;66;65	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	300	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	851	18.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	164	G,T	160,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	151	C	151	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	146	C	144	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	198	T	198	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	221	C,T	218,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	128	C	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	127	A,C	126,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	128	A	128	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	130	A	130	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	121	T	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	119	C	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	114	C	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	114	A	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	115	G	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	112	C	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	120	T	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	168	G	167	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	181	G	181	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	180	T	180	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	193	T	193	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	180	G,T	178,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	143	C	141	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	138	A	138	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	134	C	132	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	137	C	137	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	78	A	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	79	A	78	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	68	G	68	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	51	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	104	T	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	113	G	113	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	47	T	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c17.ctg.2	518	173.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	271	C	271	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	C990G	SNP	990	990	C	36	36	G	27	G	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	T1002A	SNP	1002	1002	T	48	48	A	35	A	35	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	A1004G	SNP	1004	1004	A	50	50	G	38	G	38	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	C1011T	SNP	1011	1011	C	57	57	T	44	T	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	C1023A	SNP	1023	1023	C	69	69	A	52	A	52	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	T1024A	SNP	1024	1024	T	70	70	A	53	A	53	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	T1041G	SNP	1041	1041	T	87	87	G	59	G	58	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	139	90.65	Pasteurella_multocida_16S.l15.c17.ctg.5	139	33.9	0	.	n	.	0	A1042T	SNP	1042	1042	A	88	88	T	58	T	58	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	C990G	SNP	990	990	C	40	40	G	35	G	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	T1002A	SNP	1002	1002	T	52	52	A	28	A	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	A1003C	SNP	1003	1003	A	53	53	C	28	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	G1008C	SNP	1008	1008	G	58	58	C	27	C	26	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	C1011T	SNP	1011	1011	C	61	61	T	29	T	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	T1012C	SNP	1012	1012	T	62	62	C	29	C	28	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	C1023A	SNP	1023	1023	C	72	72	A	40	A	39	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	.1025G	INS	1025	1025	T	75	75	G	44	G	44	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	T1041G	SNP	1041	1041	T	91	91	G	57	G	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	4084	Pasteurella_multocida_16S	1551	143	90.28	Pasteurella_multocida_16S.l15.c17.ctg.6	143	45.1	0	.	n	.	0	A1042T	SNP	1042	1042	A	92	92	T	57	T	57	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1068	PmrB_1	1092	1092	99.08	PmrB_1.l6.c17.ctg.1	1509	37.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	196	198	CGT	25;24;24	C;G;T	25;24;24	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1068	PmrB_1	1092	1092	99.08	PmrB_1.l6.c17.ctg.1	1509	37.6	0	.	p	.	0	V30I	NONSYN	88	90	GTC	280	282	ATC	48;47;48	A;T;C	48;47;48	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	1068	PmrB_1	1092	1092	99.08	PmrB_1.l6.c17.ctg.1	1509	37.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1039	1041	GGC	46;46;48	G;G;C	46;46;46	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1440	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	38.3	0	.	p	.	0	R8S	NONSYN	22	24	AGA	189	191	AGC	20;20;21	A;G;C	20;20;21	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1440	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	38.3	0	.	p	.	0	I142L	NONSYN	424	426	ATA	591	593	CTA	47;47;47	C;T;A	46;46;46	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1440	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	38.3	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1110	1112	CAA	46;47;46	C;A;A	46;47;46	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1440	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	38.3	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1209	1211	GGT	46;46;43	G;G;T	46;46;43	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	1440	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2018	38.3	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1779	1781	GTT	23;22;22	G;T;T	23;22;22	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	712	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1632	23.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	620	622	GAA	27;26;25	G;A;A	27;26;25	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	712	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1632	23.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	800	802	ACC	13;13;12	A;C;C	13;13;12	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	712	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1632	23.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	920	922	ACT	18;18;18	A;C;T	18;18;18	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	712	PmrE	1167	1167	96.83	PmrE.l15.c4.ctg.1	1632	23.5	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1310	1312	ATC	22;24;25	A;T;C	22;24;25	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	872	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1414	32.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	764	aad-	789	789	100.0	aad-.l15.c30.ctg.1	1259	32.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2668	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3574	40.1	0	.	p	.	0	T85I	NONSYN	253	255	ACC	498	500	ATC	55;55;54	A;T;C	55;55;54	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	2668	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3574	40.1	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2211	2213	AAG	40;40;41	A;A;G	40;40;41	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1046	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1667	33.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	335	337	GTC	13;12;14	G;T;C	12;11;13	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	1046	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1667	33.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1076	1078	TGC	44;45;47	T;G;C	44;45;46	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2338	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3136	39.8	0	.	p	.	0	S46trunc	TRUNC	136	136	T	393	393	T	32	T	32	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2338	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3136	39.8	0	.	p	.	0	G148D	NONSYN	442	444	GGC	699	701	GAC	35;34;35	G;A;C	34;34;35	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2338	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3136	39.8	0	.	p	.	0	F240L	NONSYN	718	720	TTT	975	977	TTA	31;31;29	T;T;A	31;31;29	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2338	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3136	39.8	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1158	1160	AAT	43;46;46	A;A;T	43;46;46	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	2338	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3136	39.8	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1945	1945	T	47	T	47	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	612	acrR_2	648	648	99.54	acrR_2.l15.c17.ctg.1	1136	28.7	1	SNP	p	R45C	0	.	.	133	135	CGC	401	403	CGC	58;57;56	C;G;C	56;56;55	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	522	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1189	23.7	0	.	p	.	0	L34F	NONSYN	100	102	CTC	363	365	TTC	20;20;18	T;T;C	20;20;18	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	522	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1189	23.7	0	.	p	.	0	E122G	NONSYN	364	366	GAG	627	629	GGG	47;44;42	G;G;G	47;44;42	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	750	adiY	762	762	99.61	adiY.l6.c17.ctg.1	1269	31.6	0	.	p	.	0	V136L	NONSYN	406	408	GTT	593	595	CTT	48;48;48	C;T;T	48;47;48	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2302	alaS	2631	2631	98.86	alaS.l15.c17.ctg.1	3064	40.3	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2072	2074	GCA	34;37;40	G;C;A	34;37;40	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2302	alaS	2631	2631	98.86	alaS.l15.c17.ctg.1	3064	40.3	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2333	2335	ACC	30;30;30	A;C;C	29;30;30	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	2302	alaS	2631	2631	98.86	alaS.l15.c17.ctg.1	3064	40.3	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2642	2644	GCC	37;37;35	G;C;C	37;37;35	.	aminocoumarin resistant alaS;alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1352	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2390	30.3	0	.	p	.	0	G37A	NONSYN	109	111	GGT	294	296	GCT	15;17;19	G;C;T	15;17;19	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1352	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2390	30.3	0	.	p	.	0	D77E	NONSYN	229	231	GAT	414	416	GAG	15;15;14	G;A;G	15;15;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1352	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2390	30.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	450	452	TGC	16;16;19	T;G;C	15;15;19	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1352	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2390	30.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	633	635	GTT	21;21;21	G;T;T	21;21;21	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1352	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2390	30.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	783	785	CAC	34;32;33	C;A;C	34;32;33	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1352	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2390	30.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1068	1070	ATG	49;51;50	A;T;G	49;50;50	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	1352	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2390	30.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2064	2066	CGC	23;23;26	C;G;C	23;23;26	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	652	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1283	27.2	0	.	p	.	0	S221T	NONSYN	661	663	AGC	890	892	ACC	37;37;36	A;C;C	37;37;36	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	652	bacA	822	822	98.54	bacA.l15.c4.ctg.1	1283	27.2	0	.	p	.	0	P225S	NONSYN	673	675	CCG	902	904	TCG	38;40;40	T;C;G	38;39;40	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	492	baeR	723	723	97.79	baeR.l15.c17.ctg.1	1251	21.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	964	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1774	28.9	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1281	1283	AAA	15;16;17	A;A;A	13;16;17	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	964	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1774	28.9	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1293	1295	GAG	14;16;17	G;A;G	14;16;15	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	964	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1774	28.9	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1299	1301	CAC	20;21;21	C;A;C	20;21;21	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	964	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	1774	28.9	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1353	1355	GAG	16;17;17	G;A;G	16;17;17	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	1180	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1832	34.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	734	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1165	33.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	806	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1359	31.6	0	.	p	.	0	A146T	NONSYN	436	438	GCT	611	613	ACT	36;36;38	A;C,G;T	36;35,1;38	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	dfrA1.manually_added_NC_007384_WP_000777554.1_4111923_4112396	1	0	27	472	dfrA1_1	474	474	100.0	dfrA1_1.l15.c4.ctg.1	960	26.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	942	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1661	30.2	0	.	p	.	0	I219V	NONSYN	655	657	ATC	887	889	GTC	31;31;30	G;T,A;C	31;30,1;30	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	1338	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	2096	34.2	0	.	p	.	0	E197K	NONSYN	589	591	GAA	861	863	AAA	41;42;42	A;A;A	40;40;40	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	954	emrD	1191	1191	98.4	emrD.l6.c4.ctg.1	1645	30.9	0	.	p	.	0	G209S	NONSYN	625	627	GGC	855	857	AGC	34;33;35	A;G;C	34;33;34	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	38	emrE_1	333	214	91.12	emrE_1.l15.c30.ctg.1	214	3.0	0	.	p	.	0	I100V	NONSYN	298	300	ATT	186	188	GTC	1;1;1	G;T;C	1;1;1	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	528	38	emrE_1	333	214	91.12	emrE_1.l15.c30.ctg.1	214	3.0	0	.	p	.	0	T108A	NONSYN	322	324	ACA	210	212	GCA	1;1;1	G;C;A	1;1;1	.	emrE;EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	900	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1604	30.0	0	.	p	.	0	K176R	NONSYN	526	528	AAG	805	807	AGG	31;32;33	A;G;G	31;32;33	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	900	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1604	30.0	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1195	1197	GAC	26;26;25	G;A;C	26;26;25	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	524	emrR	531	531	100.0	emrR.l6.c30.ctg.1	1084	26.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	1356	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2011	36.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	514	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1125	24.4	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	432	434	CTG	37;39;37	C;T;G	37;39;37	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	373	375	ATA	34;35;36	A;T;A	34;35;36	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	L42V	NONSYN	124	126	CTA	385	387	GTA	30;31;32	G;T;A	30;31;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	A93T	NONSYN	277	279	GCG	538	540	ACG	23;26;28	A;C;G	23;26;28	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	A114E	NONSYN	340	342	GCA	601	603	GAA	22;23;23	G;A;A	22;23;22	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	T127A	NONSYN	379	381	ACT	640	642	GCT	13;14;14	G;C;T	13;13;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	N133D	NONSYN	397	399	AAT	658	660	GAT	13;13;14	G;A;T	13;13;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	P162S	NONSYN	484	486	CCA	745	747	TCA	20;20;19	T;C;A	19;20;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	874	876	CAG	14;14;14	C;A;G	14;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1012	1014	GTT	10;11;11	G;T;T	10;11;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1168	1170	GAT	12;12;12	G;A;T	12;12;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1336	1338	AAT	17;17;16	A;A;T	17;17;16	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1357	1359	TTA	14;13;13	T;T;A	14;13;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1558	1560	AAA	20;21;21	A;A;A	20;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2293	2295	CAT	24;25;25	C;A;T	24;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2347	2349	CAT	23;24;24	C;A;T	23;24;24	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2365	2367	AGA	26;25;25	A;G;A	26;25;25	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2380	2382	AAT	31;31;29	A;A;T	31;31;29	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2527	2529	TCC	19;20;21	T;C;C	19;20;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2692	2694	ATT	41;42;40	A;T;T	40;42;40	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2713	2715	GAT	33;32;32	G;A;T	33;31;32	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2827	2829	GTT	30;31;33	G;T;T	30;31;33	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	2450	evgS	3594	3594	97.52	evgS.l15.c4.ctg.1	4171	31.6	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3112	3114	CAC	38;37;37	C;A;C	38;35;37	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	756	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1317	31.0	1	SNP	p	P64A	0	.	.	190	192	CCA	413	415	CCA	58;59;59	C;C;A	57;58;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	756	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1317	31.0	1	SNP	p	P64H	0	.	.	190	192	CCA	413	415	CCA	58;59;59	C;C;A	57;58;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	756	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1317	31.0	1	SNP	p	P64L	0	.	.	190	192	CCA	413	415	CCA	58;59;59	C;C;A	57;58;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	756	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1317	31.0	1	SNP	p	P64S	0	.	.	190	192	CCA	413	415	CCA	58;59;59	C;C;A	57;58;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	756	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1317	31.0	1	SNP	p	P64R	0	.	.	190	192	CCA	413	415	CCA	58;59;59	C;C;A	57;58;57	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	508	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1058	25.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	238	96.22	gadW.l15.c4.ctg.1	340	12.1	0	.	p	.	0	S234A	NONSYN	700	702	TCG	209	211	GCG	11;11;11	G;C;G	11;11;11	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	L46P	NONSYN	136	138	CTG	11	13	CCG	1;1;1	C;C;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	E54D	NONSYN	160	162	GAA	35	37	GAT	3;3;3	G;A;T	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	137	139	ATG	3;3;3	A;T;G	3;3;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	140	142	CCG	3;3;3	C;C;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	173	175	GAA	4;4;4	G;A;A	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	176	178	TCC	4;4;4	T;C;C	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	179	181	GGG	4;4;4	G;G;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	132	gadW	729	369	92.95	gadW.l15.c4.ctg.2	369	7.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	203	205	AAT	4;4;5	A;A;T	4;4;5	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	598	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1301	24.6	0	.	p	.	0	F53L	NONSYN	157	159	TTC	387	389	TTA	29;29;30	T;T;A	29;29;30	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	598	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1301	24.6	0	.	p	.	0	V79I	NONSYN	235	237	GTT	465	467	ATT	31;31;30	A;T;T	31;31;30	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	598	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1301	24.6	0	.	p	.	0	R246G	NONSYN	736	738	AGA	966	968	GGA	13;13;13	G;G;A	13;13;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	598	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1301	24.6	0	.	p	.	0	S248P	NONSYN	742	744	TCG	972	974	CCG	12;13;12	C;C;G	12;13;12	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2376	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3164	40.4	1	SNP	p	S83L	1	S83L	NONSYN	247	249	TCG	453	455	TTG	46;45;44	T;T;G	46;45;44	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2376	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3164	40.4	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2238	2240	GAA	50;49;50	G;A;A	50;49;49	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2376	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3164	40.4	1	SNP	p	D87N	0	.	.	259	261	GAC	465	467	GAC	45;46;46	G;A;C	45;46;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2376	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3164	40.4	1	SNP	p	D87G	0	.	.	259	261	GAC	465	467	GAC	45;46;46	G;A;C	45;46;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2376	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3164	40.4	1	SNP	p	D87H	0	.	.	259	261	GAC	465	467	GAC	45;46;46	G;A;C	45;46;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2376	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3164	40.4	1	SNP	p	D87V	0	.	.	259	261	GAC	465	467	GAC	45;46;46	G;A;C	45;46;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	2376	gyrA_7	2628	2628	98.67	gyrA_7.l6.c30.ctg.1	3164	40.4	1	SNP	p	D87Y	0	.	.	259	261	GAC	465	467	GAC	45;46;46	G;A;C	45;46;45	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2066	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3033	36.6	1	SNP	p	R136G	0	.	.	406	408	CGC	695	697	CGC	34;34;33	C;G;C	34;34;33	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2066	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3033	36.6	1	SNP	p	R136I	0	.	.	406	408	CGC	695	697	CGC	34;34;33	C;G;C	34;34;33	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2066	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3033	36.6	1	SNP	p	R136S	0	.	.	406	408	CGC	695	697	CGC	34;34;33	C;G;C	34;34;33	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2066	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3033	36.6	1	SNP	p	R136L	0	.	.	406	408	CGC	695	697	CGC	34;34;33	C;G;C	34;34;33	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2066	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3033	36.6	1	SNP	p	R136C	0	.	.	406	408	CGC	695	697	CGC	34;34;33	C;G;C	34;34;33	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2066	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3033	36.6	1	SNP	p	R136H	0	.	.	406	408	CGC	695	697	CGC	34;34;33	C;G;C	34;34;33	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	2066	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	3033	36.6	1	SNP	p	R136E	0	.	.	406	408	CGC	695	697	CGC	34;34;33	C;G;C	34;34;33	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	516	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1133	24.4	0	.	p	.	0	A72P	NONSYN	214	216	GCG	441	443	CCG	31;30;30	C;C;G	30;29;30	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	516	kdpE	678	678	98.23	kdpE.l15.c4.ctg.1	1133	24.4	0	.	p	.	0	T123A	NONSYN	367	369	ACC	594	596	GCC	29;31;31	G;C;C	28;31;31	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	890	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1433	33.3	0	.	p	.	0	P9S	NONSYN	25	27	CCA	196	198	TCA	23;24;27	T;C;A	23;24;27	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	332	marA	384	384	99.74	marA.l15.c4.ctg.1	893	20.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	534	536	AGC	13;13;12	A;G;C	13;13;12	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	636	638	CAT	9;9;10	C;A;T	8;9;10	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	V45E	0	.	.	133	135	GTG	360	362	GTG	32;32;32	G;T;G	32;31;32	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	I49S	0	.	.	145	147	ATC	372	374	ATC	29;29;29	A;T;C	29;29;29	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	A70T	0	.	.	208	210	GCA	435	437	GCA	32;32;32	G;C;A	32;32;32	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	R73C	0	.	.	217	219	CGT	444	446	CGT	33;32;31	C;G;T	33;32;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	R73S	0	.	.	217	219	CGT	444	446	CGT	33;32;31	C;G;T	33;32;31	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	R77C	0	.	.	229	231	CGC	456	458	CGC	27;26;26	C;G;C	27;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	R77L	0	.	.	229	231	CGC	456	458	CGC	27;26;26	C;G;C	27;26;26	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	L78M	0	.	.	232	234	CTG	459	461	CTG	26;24;24	C;T;G	26;24;24	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	R94S	0	.	.	280	282	CGC	507	509	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	R94H	0	.	.	280	282	CGC	507	509	CGC	11;11;11	C;G;C	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	244	marR	435	435	97.7	marR.l15.c30.ctg.1	746	17.2	1	SNP	p	V96E	0	.	.	286	288	GTA	513	515	GTA	11;11;11	G;T;A	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	S7F	NONSYN	19	21	TCC	218	220	TTC	6;6;6	T;T;C	6;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	R36I	NONSYN	106	108	AGG	305	307	ATC	15;13;13	A;T;C	15;13;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	E42A	NONSYN	124	126	GAA	323	325	GCC	5;5;5	G;C;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	N43V	NONSYN	127	129	AAT	326	328	GTG	5;4;4	G;T;G	5;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	353	355	GAT	7;7;7	G;A;T	7;7;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	374	376	ACC	13;12;12	A;C;C	13;12;12	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	401	403	TTA	20;20;20	T;T;A	20;20;20	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	542	544	CAG	42;43;41	C;A;G	42;43;41	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	581	583	GCC	30;31;30	G;C;C	30;31;30	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	686	688	GCG	30;30;29	G;C;G	30;30;29	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	890	892	GTT	22;22;22	G;T;T	20;19;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	718	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1693	22.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1052	1052	C	26	C	26	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	738	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1761	22.5	0	.	p	.	0	V12trunc	TRUNC	34	34	G	301	301	G	35	G	35	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	738	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1761	22.5	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	358	360	CAG	19;19;18	C;A;G	19;18;18	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	738	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1761	22.5	0	.	p	.	0	T83I	NONSYN	247	249	ACC	508	510	ATC	35;34;29	A;T;C	34;33;29	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	738	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1761	22.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	556	558	ATG	13;13;14	A;T;G	13;13;14	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	738	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1761	22.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	649	651	ACC	20;22;22	A;C;C	20;22;22	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	738	mdtA	1248	1248	97.36	mdtA.l6.c30.ctg.1	1761	22.5	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1030	1032	ACG	33;33;31	A;C;G	33;33;31	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2524	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3557	38.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1976	1978	ACC	43;41;40	A;C;C	43;41;40	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2524	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3557	38.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2369	2371	CAA	35;35;35	C;A;A	34;34;35	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2524	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3557	38.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2537	2539	ATT	28;27;26	A;T;T	28;27;26	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2524	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3557	38.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2621	2623	GTT	18;18;16	G;T;T	18;17;16	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2524	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3557	38.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2729	2731	GAG	31;32;32	G;A,C;G	30;30,1;31	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2524	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3557	38.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2957	2959	ATG	33;34;34	A;T;G	33;34;34	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	2524	mdtB	3123	3123	98.98	mdtB.l6.c4.ctg.1	3557	38.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3092	3094	GAT	24;26;27	G;A;T	24;26;27	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2128	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3484	32.8	0	.	p	.	0	I46M	NONSYN	136	138	ATC	323	325	ATG	14;13;15	A;T;G	14;13;15	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2128	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3484	32.8	0	.	p	.	0	V208I	NONSYN	622	624	GTC	809	811	ATC	36;36;35	A;T;C	36;36;35	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2128	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3484	32.8	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3125	3127	CAC	17;19;18	C;A;C	17;18;18	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	2128	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3484	32.8	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3128	3130	CTC	18;18;18	C;T;C	18;17;18	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1100	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1975	30.0	0	.	p	.	0	D3E	NONSYN	7	9	GAT	255	257	GAA	21;21;21	G;A;A	21;20;21	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1100	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1975	30.0	0	.	p	.	0	T226A	NONSYN	676	678	ACG	924	926	GCG	31;31;35	G;C;G	31;30;35	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1100	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1975	30.0	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1266	1268	ATC	41;40;39	A;T;C	40;40;39	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	1100	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1975	30.0	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1569	1571	TTT	39;38;40	T;T;T	39;38;40	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	1176	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1631	38.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2724	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3670	39.9	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1138	1140	ACC	40;39;37	A;C;C	40;39;37	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	2724	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3670	39.9	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2380	2382	GAC	31;32;35	G;A;C	30;32;35	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1102	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1607	30.4	0	.	p	.	0	V200I	NONSYN	598	600	GTC	652	654	ATC	31;30;30	A;T;C	31;30;29	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	1102	mdtG	1227	182	99.45	mdtG.l15.c17.ctg.2	604	16.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	217	219	GGA	15;15;13	G;G;A	15;15;13	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	892	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1652	29.0	0	.	p	.	0	G134C	NONSYN	400	402	GGT	636	638	TGT	26;26;25	T;G;T	26;26;25	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	892	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1652	29.0	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1206	1208	TTG	33;32;32	T;T;G	33;31;32	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	892	mdtH	1209	1209	98.18	mdtH.l15.c30.ctg.1	1652	29.0	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1416	1418	ACG	8;7;7	A;C;G	8;7;7	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	960	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1723	29.8	0	.	p	.	0	A185S	NONSYN	553	555	GCC	838	840	TCC	27;27;26	T;C;C	25;27;26	.	mdtL;Multidrug resistance protein MdtL
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2804	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3821	39.4	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1472	1474	AAG	29;29;29	A;A;G	29;29;29	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	2804	mfd	3447	3447	99.13	mfd.l15.c4.ctg.1	3821	39.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2549	2551	CTG	51;50;50	C;T;G	51;50;50	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	224	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	677	17.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1654	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2302	38.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1080	1082	AAC	29;30;29	A;A;C	29;29;29	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	1654	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	2302	38.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1626	1628	ATA	63;62;64	A;T;A	62;62;63	.	msbA;MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1156	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1732	35.9	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1340	1342	GAT	46;46;48	G;A;T	46;46;48	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	1156	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1732	35.9	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1343	1345	CTG	50;49;49	C;T;G	49;49;48	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	286	288	TGT	23;24;23	T;G;T	23;24;23	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	556	558	ACC	29;29;32	A;C;C	28;29;32	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	766	768	GAC	25;25;25	G;A;C	24;25;25	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	1	SNP	p	R15C	0	.	.	43	45	CGC	250	252	CGC	51;45;44	C;G;C	51;45;44	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	1	SNP	p	S33R	0	.	.	97	99	AGC	304	306	AGC	31;31;31	A;G;C	31;30;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	1	SNP	p	G131D	0	.	.	391	393	GGC	598	600	GGC	47;47;46	G;G,A;C	47;46,1;45	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	1	SNP	p	R203L	0	.	.	607	609	CGT	814	816	CGT	31;30;30	C;G,C;T	31;29,1;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	594	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1144	27.6	1	SNP	p	R203C	0	.	.	607	609	CGT	814	816	CGT	31;30;30	C;G,C;T	31;29,1;30	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1134	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1624	37.4	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1206	1208	GAG	45;46;44	G;A;G	45;45;44	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1134	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1624	37.4	1	SNP	p	G141D	0	.	.	421	423	GGT	693	695	GGT	60;61;61	G;G;T	60;61;61	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1134	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1624	37.4	1	SNP	p	G141E	0	.	.	421	423	GGT	693	695	GGT	60;61;61	G;G;T	60;61;61	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1134	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1624	37.4	1	SNP	p	R154A	0	.	.	460	462	CGT	732	734	CGT	71;70;69	C;G;T	71;70;69	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	1134	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1624	37.4	1	SNP	p	R154D	0	.	.	460	462	CGT	732	734	CGT	71;70;69	C;G;T	71;70;69	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2174	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2794	41.8	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1903	1905	GTG	49;49;48	G,A;T;G	48,1;49;47	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2174	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2794	41.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1930	1932	TCG	52;52;50	T;C;G	43;50;50	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2174	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2794	41.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2545	2547	AAC	23;23;24	A;A;C	23;23;24	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2174	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2794	41.8	1	SNP	p	A85T	0	.	.	253	255	GCG	559	561	GCG	52;50;51	G;C;G	50;48;51	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2174	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2794	41.8	1	SNP	p	D111H	0	.	.	331	333	GAT	637	639	GAT	38;38;38	G;A;T	38;38;38	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	2174	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2794	41.8	1	SNP	p	S129P	0	.	.	385	387	TCC	691	693	TCC	51;53;52	T;C;C	50;53;50	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1306	parE_1	1893	1893	97.52	parE_1.l15.c17.ctg.1	2525	27.9	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1713	1715	AAC	30;32;34	A;A;C	30;32;34	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	1306	parE_1	1893	1893	97.52	parE_1.l15.c17.ctg.1	2525	27.9	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1722	1724	GAT	36;37;37	G;A;T	34;37;36	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1288	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1952	35.4	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	850	852	CAG	47;48;49	C;A;G	47;48;49	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	1288	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1952	35.4	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1324	1326	GAT	44;41;41	G;A;T	44;41;41	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	V146F	0	.	.	436	438	GTT	693	695	GTT	53;53;53	G;T;T	53;53;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1794	1796	CAG	64;66;67	C;A;G	64;66;67	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1794	1796	CAG	64;66;67	C;A;G	64;66;67	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1833	1835	CAC	60;60;60	C;A;C	60;60;60	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1842	1844	CGT	55;54;54	C;G;T	55;53;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1842	1844	CGT	55;54;54	C;G;T	55;53;53	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1848	1850	TCC	48;48;48	T;C;C	47;48;48	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1854	1856	CTC	45;44;43	C;T;C	45;44;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1944	1946	ACC	49;50;49	A;C;C	49;50;49	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1947	1949	CCT	45;44;43	C;C;T	45;44;43	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	3894	rpoB	4029	4029	99.03	rpoB.l6.c30.ctg.1	4627	45.3	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2316	2318	CGT	61;57;55	C;G;T	61;57;55	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	.	n	.	0	A226G	SNP	226	226	A	353	353	G	329	G	329	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	A794G	0	.	.	794	794	A	921	921	A	363	A	356	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	A794T	0	.	.	794	794	A	921	921	A	363	A	356	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	G926C	0	.	.	926	926	G	1053	1053	G	321	G	321	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	G926T	0	.	.	926	926	G	1053	1053	G	321	G	321	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	G926A	0	.	.	926	926	G	1053	1053	G	321	G	321	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	1646	1646	A	312	A	310	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	1646	1646	A	312	A	310	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	1646	1646	A	312	A	310	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	C194T,A	.	194	194	C	321	321	C	351	C,T,A	263,85,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	A250T	.	250	250	A	377	377	A	312	A,T	251,57	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	G1002A	.	1002	1002	G	1129	1129	G	301	G,A	179,122	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	G474A	.	474	474	G	601	601	G	349	G,A	261,85	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	G1006C	.	1006	1006	G	1133	1133	G	306	G,C	179,123	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	A79G	.	79	79	A	206	206	A	329	A,G	251,76	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	C719T	.	719	719	C	846	846	C	301	C,T	176,121	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	T273A	.	273	273	T	400	400	T	338	T,A	262,72	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	T1010C	.	1010	1010	T	1137	1137	T	304	T,C	175,122	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	C1038T	.	1038	1038	C	1165	1165	C	331	C,T	189,141	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	C183T	.	183	183	C	310	310	C	355	C,T	216,137	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	T90C	.	90	90	T	217	217	T	322	T,C	251,67	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	659	11082	rrsB+	1542	1542	99.94	rrsB+.l6.c17.ctg.1	1968	294.5	0	HET	.	.	.	A253T	.	253	253	A	380	380	A	313	A,T	252,56	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	596	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1077	29.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	474	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1012	25.1	1	SNP	p	R20H	0	.	.	58	60	CGC	345	347	CGC	37;37;37	C;G;C	37;37;37	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	474	soxR	465	465	100.0	soxR.l15.c30.ctg.1	1012	25.1	1	SNP	p	G121D	0	.	.	361	363	GGT	648	650	GGT	44;45;46	G;G;T	44;45;46	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	418	soxS_1	324	324	99.69	soxS_1.l15.c30.ctg.1	940	23.8	1	SNP	p	A12S	0	.	.	34	36	GCA	365	367	GCA	58;58;56	G;C;A	58;58;55	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	27	1616	APH_3____Ib+	804	804	100.0	APH_3____Ib+.l15.c4.ctg.1	1297	66.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	1642	APH_6__Id+	837	837	100.0	APH_6__Id+.l6.c30.ctg.1	1373	64.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	1240	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1287	51.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	1834	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1733	56.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	1142	tetR	651	651	100.0	tetR.l15.c30.ctg.1	1225	50.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	1370	tolC	1488	1488	98.72	tolC.l15.c4.ctg.1	1990	36.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
